Company Overview and News

34
Market Update: PSU banks push Nifty higher led by BoB, PNB; RIL, GAIL up 1-3%, PC Jeweller zooms 38%

2018-05-07 moneycontrol
The Indian equity market extended gains and was trading on a positive note on Monday afternoon with the Nifty gaining 79 points and was trading at a shade below 10,700 at 10,697 while the Sensex was up 248 points or 0.71 percent.
500325 532714 539437 532483 534816 GAILF CLNDY RLNIY SBAZ TVSMOTOR AXB 501425 APOLLOTYRE YYBKY AYRQY BBTC CNRYY AXBA GAILY 534809 TCS HINDPETRO PCJEWELLER 500104 CANBK COALINDIA BHRYY 533150 RELIANCE 533273 TTNQY 533278 532215 532343 532540 IDFCBANK 532461 AXISBANK RIGD INFRATEL KEC YESBANK HINDALCO 500877 IBN 532648 AXBKY HNDNF ICICIBANK OBZIY GODREJPROP OBEROIRLTY PNJZY 532174 501455 PNB GREAVESCOT 500440

39
Market Update: Axis Bank, Hindalco up 2-3% while Lupin sheds 3%; Jubilant Food hits new 52-week high

2018-05-07 moneycontrol
The Indian equity market extended loses was trading on a negative note on Monday afternoon with the Nifty gaining 36 points was trading at 10,654 while the Sensex was up 96 points or 0.28 percent.
531500 539437 532960 532483 EICHERMOT CLNDY SBAZ RAJESHEXPO AXB 501425 BBTC CNRYY AXBA TATASTEEL TATLY 534809 TCS HINDPETRO PCJEWELLER 500104 CANBK COALINDIA 533150 533273 TTNQY 533278 IDBLZ 532215 505200 500470 532540 IDFCBANK 532461 AXISBANK ECQRY HINDALCO IBVENTURES IBN AXBKY HNDNF ICICIBANK OBZIY GODREJPROP TTST OBEROIRLTY PNJZY 532174 PNB 500440

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...